Abstract
In this study, we compared complete pathological downstaging (pCD, ≤(y)pT1N0) and overall survival (OS) in patients with cT2 versus cT3-4aN0M0 UC of the bladder undergoing radical cystectomy (RC) with or without neoadjuvant chemo- (NAC) or radiotherapy (NAR). A population-based sample of 5,517 patients, who underwent upfront RC versus NAC + RC or NAR + RC for cT2-4aN0M0 UC between 1995-2013, was identified from the Netherlands Cancer Registry. Data were retrieved from individual patient files and pathology reports. pCD-rates were compared using Chi-square tests and OS was estimated by Kaplan-Meier analyses. Multivariable analyses were conducted to determine odds (OR) and hazard ratios (HR) for pCD-status and OS, respectively. We included 4,504 (82%) patients with cT2 and 1,013 (18%) with cT3-4a UC. Median follow-up was 9.2 years. In cT2 UC, pCD-rate was 25% after upfront RC versus 43% (p < 0.001) and 33% (p = 0.130) after NAC + RC and NAR + RC, respectively. In cT3-4a UC, pCD-rate was 8% after upfront RC versus 37% (p < 0.001) and 16% (p = 0.281) after NAC + RC and NAR + RC, respectively. In cT2 UC, 5-year OS was 57% and 51% for NAC + RC and upfront RC, respectively (p = 0.135), whereas in cT3-4a UC, 5-year OS was 55% for NAC +...Continue Reading
References
Jan 1, 1977·Journal of Surgical Oncology·N H SlackG R Prout
Jun 1, 1979·Cancer·G R ProutW U Shipley
Aug 29, 2003·The New England Journal of Medicine·H Barton GrossmanE David Crawford
Jun 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry W HerrE David Crawford
Jun 9, 2005·European Urology·UNKNOWN Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
Jun 9, 2005·European Urology·UNKNOWN Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
Jan 25, 2006·BJU International·John P SteinDonald G Skinner
Apr 14, 2009·Scandinavian Journal of Urology and Nephrology·Torvald GranforsBörje Ljungberg
Aug 27, 2010·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·V PaleriR G Wight
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN International Collaboration of TrialistsMahesh K B Parmar
Dec 23, 2011·European Urology·Robert RosenblattUNKNOWN Nordic Urothelial Cancer Group
Aug 6, 2013·The Journal of Urology·Stephen H CulpColin P N Dinney
Sep 7, 2013·BJU International·R Houston ThompsonIgor Frank
Dec 5, 2013·The Journal of Urology·Hugh J LaveryMichael J Droller
Jan 1, 2014·European Urology·J Alfred WitjesAmir Sherif
Jan 30, 2014·European Urology·Zachary D ReardonMichael S Cookson
Sep 27, 2014·European Urology·Homayoun ZargarPeter C Black
Apr 25, 2015·Clinical Genitourinary Cancer·Dayssy Alexandra DiazMatthew C Abramowitz
Nov 3, 2015·The Journal of Urology·Homayoun ZargarUNKNOWN Collaborators
Nov 13, 2015·European Urology·Jennifer R Rider
Dec 29, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tom J N HermansBas W G van Rhijn
Aug 6, 2016·Urologic Oncology·Tom Johannes Noël HermansSimon Horenblas
Nov 13, 2017·Urologic Oncology·Tom J N HermansBas W G van Rhijn
Citations
Nov 6, 2020·BJU International·Francesco SoriaPaolo Gontero
Feb 16, 2021·European Urology Oncology·Charlotte S VoskuilenLaura S Mertens
Oct 16, 2020·BMC Urology·Agus Rizal A H HamidRainy Umbas
Mar 9, 2021·International Journal of Urology : Official Journal of the Japanese Urological Association·Masashi KubotaOsamu Ogawa
Nov 28, 2019·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Y NeuzilletP Mongiat-Artus
Sep 30, 2021·World Journal of Urology·L M C van HoogstratenT J N Hermans